CLINICAL_TRIALS
trial_result
· 2017-03-20
Clinical Trial Update: B0151005 Open-Label Extension Study [Phase 2]
Summary
Open-label extension study (Phase 2) for Crohn's disease completed; results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Pfizer | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-03-20